Home › Kidney Failure › Maryland › Baltimore
Kidney Failure clinical trials in Baltimore, MD
5 studies for Kidney Failure are looking for participants at sites in and around Baltimore (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
RecruitingPhase 1/2Healthy volunteers welcome
- Research Site, Baltimore
Incremental Hemodialysis: The TwoPlus Trial
Recruiting
- Johns Hopkins University School of Medicine (JHUSM), Baltimore
CAPABLE Transplant
Recruiting
- Johns Hopkins School of Nursing, Baltimore
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
Recruiting
- University of Maryland, Baltimore
Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors
RecruitingHealthy volunteers welcome
- The Johns Hopkins Hospital, Baltimore
About Kidney Failure
Healthy kidneys clean your blood by removing excess from your body. But if kidneys are damaged, they won't work properly. Read about the treatments.
More about Kidney Failure on MedlinePlus
Kidney Failure trials in other cities
- Boston, MA14 studies
- Houston, TX13 studies
- Dallas, TX9 studies
- Chicago, IL7 studies
- New York City, NY7 studies
- Queens, NY6 studies
- Orlando, FL5 studies
- Atlanta, GA5 studies
- Durham, NC5 studies
- Phoenix, AZ5 studies
- Los Angeles, CA4 studies
- Mountain View, CA4 studies
Other studies in Baltimore
- Non-Small Cell Lung Cancer60 studies
- Breast Cancer47 studies
- Prostate Cancer42 studies
- Lung Cancer40 studies
- Cancer (all types)38 studies
- Pancreatic Cancer32 studies
- Colorectal Cancer31 studies
- Metastatic Cancer28 studies
- Obesity25 studies
- Heart Failure24 studies
- Bladder Cancer24 studies
- Stroke22 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.